Scientists confronted with local controversy over recombinant DNA research often turned to Singer for advice and information on how to counter the arguments of opponents and defend the safety of this research. In this letter, Singer warned of the complications and multiple regulations that would arise if local jurisdictions rather than federal institutions were allowed to oversee recombinant DNA technology. She also urged that the NIH Guidelines for Recombinant DNA research be applied to all such research no matter how it was funded, including research conducted by private industry.
Copyright:
This item may be under copyright protection; contact the copyright owner for permission before re-use.